Image Guided Surgery Devices Market Size, Share and Trends 2026 to 2035

What is the Image Guided Surgery Devices Market Size?

The global image guided surgery devices market size is estimated at USD 8.96 billion in 2025 and is anticipated to reach around USD 22.64 billion by 2035, expanding at a CAGR of 9.71% from 2026 to 2035.

Image Guided Surgery Devices Market Key Takeaways

• The North America region has captured a 42% revenue share in 2025.
• By product, the devices segment has contributed 76% revenue share in 2025.
• The software product segment accounted for 23.7% of revenue share in 2025.

Market Overview

The sector is primarily driven by the increase in the elderly population, the demand for less invasive procedures, and technical developments in imaging systems. The market is growing as a result of the rising prevalence of chronic diseases like cancer as well as the increase in efforts for cancer treatment.

For instance, a global organisation for cancer research estimates that there will be around 19,292,789 new cases of cancer in 2020. In response to the COVID dilemma, the industry participants are concentrating on creating remote solutions, such as cloud-based training on virtual computers, to offer remote counselling and assistance to the patients. In order to give healthcare professionals access to online training for the Philips Ultrasound Affiniti system, Royal Philips and LeQuest teamed in November 2020.

A surgical technique known as image guided surgery involves the use of stained surgical instruments and preoperative or intraoperative photographs by the surgeon to either directly or indirectly influence the process. Image-guided surgery techniques employ cameras, ultrasonic, electromagnetic, or a combination of fields to record and transmit the patient's physical characteristics and the surgeon's precise progress with respect to the patient to computer monitors in the operating room or AR headsets.

Equipment for image-guided surgery supports the diagnosis and treatment of a variety of disorders. Using image-guided surgical technology allows for more accurate and effective surgery. Endoscopic sinus surgery (ESS), though originally developed for neurosurgery, quickly rose to the top of its uses. One of the most significant developments in endoscopic sinus surgery since the beginning of the endoscopic method is image-guided surgery. With the use of this technology, the surgeon may watch the anatomical dissection of the sinuses in real time on a computer display in the operating room.

Artificial Intelligence: The Next Growth Catalyst in Image Guided Surgery Devices

AI is profoundly impacting the image-guided surgery (IGS) devices industry by enhancing precision, efficiency, and patient outcomes through advanced data analytics and machine learning algorithms. AI algorithms improve the quality of medical images by performing tasks like noise reduction and contrast enhancement, which enables better visualization of anatomical structures during procedures.

Image Guided Surgery Devices Market Growth Factors

Approximately 16% of the world's population, or one in six individuals, will be over 65 by 2050, up from 9% in 2019, predicts the United Nations' World Population Prospects. According to the WHO, chronic illnesses such excessive cholesterol, hypertension, cancer, and cognitive heart disorders are replacing infections as the leading cause of mortality worldwide. Thus, it is anticipated that there will be an increase in demand for image-guided treatment systems in the upcoming years to treat these illnesses.

The demand for minimally intrusive treatments is another factor driving business expansion. The adoption of minimally invasive techniques for some common operations can lower postoperative problems and can also decrease healthcare expenditures, according to a nationwide survey research by Johns Hopkins Medicine. As a result, the market is anticipated to grow as a result of the rising demand for less invasive image-guided treatments.

In the UK, radiation is used to treat more than 120,000 patients each year, according to the Institute of Cancer Research. Systems for image-guided treatment have substantially advanced, enabling procedures that are safer and more accurate. For instance, GE Healthcare introduced the Allia IGS 7 angiography system in December 2020. The system was expected to promote workflow effectiveness, simplify the adoption of enhanced image guidance in everyday practise, and improve user experience.

The market is expanding as a result of several initiatives to promote cancer radiation and rising private sector investments in the creation of sophisticated image-guided treatment devices. Several organisations engaged in cancer radiation research include Cancer Research U.K., Medical Research Council, and National Institute for Health Research. For instance, the Department of RadiationOncologyat Stanford Medicine is conducting research to create platforms for minimally invasive cancer diagnosis, imaging, and therapy.

Market Outlook

• Market Growth Overview: The image-guided surgery devices market is expected to grow significantly between 2025 and 2034, driven by the rising demand for minimally invasive surgery, rising chronic diseases, and improved patient outcomes.
• Sustainability Trends: Sustainability trends involve energy-efficient devices, technological integration for efficiency, and minimally invasive surgery.
• Major Investors: Major investors in the market include Medtronic, Siemens Healthineers, GE Healthcare, Philips Healthcare, Stryker, and Brainlab AG.

Market Scope

Market Dynamics

Key Market Drivers

• The increasing aging population - Some of the key factors propelling the worldwide market for image guided surgical devices include the ageing population, the rise in neurological and chronic disorders, and the rising incidence of cancer. Due to their low levels of immunity and lengthy recovery times, the older population need intensive care. Additionally, chronic illnesses like cancer, neurological conditions, and arthritis affect elderly individuals more severely, making improved diagnostic tools and treatments more in demand. Around 12.7 million new cases of cancer were discovered worldwide in 2008, and the number is projected to raise to 21.4 million by 2030, according to the International Agency for Research on Cancer (IARC), a specialist cancer agency of the WHO that promotes cancer research.
• Technological modifications have elevated the image guided surgical equipment market - Additionally, advancements in technology have increased demand for image-guided surgical equipment globally. In contrast to more intrusive treatments, minimally invasive operations have a significantly shorter recovery time and significantly less scarring afterward. A further factor driving the market expansion for image guided surgical equipment is the rise in brain disorders, orthopaedic ailments, and trauma injuries.

Key Market Challenges

• High cost of imaging technique - The two main things that are anticipated to impede market expansion are the high cost of imaging technology and the rigorous regulatory regulations. In addition, the expansion of the market for image-guided surgical equipment is being negatively impacted by a lack of knowledge. However, the worldwide market for image guided surgical equipment has a lot of room to develop due to the rising demand and adoption of this technology in emerging nations. Moreover, throughout the projection period, this market would benefit from rising government efforts and expanding healthcare infrastructure.

Key Market Opportunities

The growing popularity of computer assisted surgery

• During the projection period, it is anticipated that the market for picture guided surgery equipment would expand more quickly due to the rising popularity of computer aided surgery. The market will grow over the projected period as augmented and virtual realities are integrated into image-guided surgery (IGS). Computed tomography (CT) scanner demand is anticipated to dominate the market in the near future.
• The use of image guided surgical tools will increase for the treatment of neurosurgical conditions. The use of these tools improves surgical accuracy and lowers the possibility of harming non-surgery regions. Throughout the projected period, image guided surgical equipment will be extensively used in cancer and neurosurgery.
• The analysis predicts that China will expand the quickest due to rising demand for minimally invasive surgical treatments, an increase in chronic illness cases, and growing government assistance.

Product Insights

In 2025, the endoscopes category had the highest revenue share more than 32%. The segment is being driven by the rising prevalence of gastrointestinal and cancer illnesses as well as the need for interventional endoscopic systems.

In addition, the endoscopes market is anticipated to grow at the highest CAGR over the forecast period due to endoscopic technology developments and subsequent product releases. For soft tissue approximation and endoscopic application of sutures, the OverStitchSx endoscopic suturing device from Apollo Endosurgery got FDA clearance in November 2017.

In 2025, Magnetic Resonance Imaging (MRI) surpassed the first-largest product group. In the upcoming years, the category is anticipated to see attractive growth potential. The main drivers of the category growth are technological developments and the broad range of applications for these therapies in treatment planning, location and delivery, and treatment response evaluation. Major applications for these systems may be found in the treatment of trauma, neurology, and radiation oncology. Thus, it is anticipated that the growing burden of these diseases would further increase product demand.

End User Insights

In 2025, the hospitals sector's revenue share was above 37%, which was the highest. The two main drivers driving the segment are the rise in different procedures and the widespread use of image-guided treatment systems in hospitals. Due to the growing demand for clinical workflows to be optimized cost-effectively, hospitals are implementing these technologies.

Over the projected period, the market for ambulatory surgical centres (ASCs) is predicted to grow at the quickest rate. This rise is linked to the benefits that these healthcare venues provide, including shorter wait times and considerable financial savings. The rising popularity of same-day surgery in developed countries is a result of substantial cost savings and superior service delivery, which also supports the segment's expansion.

Other end-use categories include research and academic institutions, specialty clinics, and hospitals. The research and academic institutions market is being driven by rising partnerships between manufacturers and research organizations as well as supportive activities for cancer treatment.

Application Insights

The category with the highest revenue share in 2025 more than 34% was cardiac surgery. In the entire world, cardiovascular diseases (CVDs) are the main cause of mortality. The primary driver of the segment's growth is the rise in the number of older people combined with the weight of these diseases. Numerous research projects carried out to produce real-time cardiac interventions are also contributing to the segment's expansion.

Over the forecast period, the neurosurgery market is anticipated to grow at a profitable CAGR of 6.2%. The main drivers of this market are the rising number of accidents and trauma cases as well as the increasing frequency of neurological illnesses. The segment's expansion is also being fueled by an increase in cooperation with important firms on the development of new image-guided therapeutic systems.

In terms of revenue share in 2022, the urology area came in second. The main purposes of image-guided therapy systems for urological applications are diagnosis, treatment planning, and treatment evaluation. The section is anticipated to be driven by rising research for the creation of novel systems employing 3D and 4D imaging, robot-assisted image-guided treatments, and molecular imaging.

Regional Insights

U.S. Image Guided Surgery Devices Market Size and Growth 2026 to 2035

The U.S. image guided surgery devices market size is evaluated at USD 2.63 billion in 2025 and is predicted to be worth around USD 6.90 billion by 2035, rising at a CAGR of 10.13% from 2026 to 2035.

The global market is segmented into North America, Europe, Asia Pacific, and the Rest of the World based on regional analysis. Due to the adoption of new technology and the availability of highly skilled professionals to carry out elaborate and sophisticated procedures, North America and Europe now have the largest market share. Additionally, the rising prevalence of neurological disorders, rising demand for minimally invasive surgery, rising healthcare awareness, growing elderly population, and rising healthcare spending are all contributing to the market's expansion in these areas.

U.S. Image Guided Surgery Devices Market Trends

U.S. market growth is driven by the integration of 4K intraoperative imaging and AI-driven precision, which is meeting the critical demand for minimally invasive procedures in oncology and neurology, significantly reducing procedural errors and tissue trauma.

Germany Image Guided Surgery Devices Market Trends

Germany's technological maturation is driving superior clinical outcomes and faster recovery times, positioning advanced visualization as the cornerstone of modern, high-throughput surgical environments.

How did the Asia Pacific experience notable growth in the Image Guided Surgery Devices Market?

Asia Pacific's rapid expansion is fueled by a rising geriatric population and the increasing prevalence of complex cardiovascular and neurological disorders.

Value Chain Analysis of Image Guided Surgery Devices Market

• Research & Development (R&D) and Product Design
  This foundational stage involves innovation in imaging modalities (CT, MRI, ultrasound) and the development of sophisticated navigation software, AI integration, and robotic assistance.
  Key Players: Medtronic, Brainlab AG, Koninklijke Philips N.V., and Siemens Healthineers.
• Raw Material Acquisition and Manufacturing
  This stage includes sourcing high-quality electronic components, sensors, cameras, and display technologies, followed by the precise assembly of complex medical devices in compliance with stringent regulatory standards.
  Key Players: GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., and Canon Medical Systems
• Distribution and Sales
  Products are moved through a combination of direct sales forces and specialized distributors to reach end-users such as hospitals, ambulatory surgical centers, and specialty clinics.
  Key Players: Medtronic, Stryker, and Johnson & Johnson

Image Guided Surgery Devices Market Companies

• GE HealthCare: GE HealthCare is a leading provider of advanced imaging technologies, offering a range of IGS systems like the Allia IGS and Innova IGS platforms that use AI to optimize image quality and dose efficiency.
• Olympus Corporation: Olympus Corporation primarily contributes to the market through its advanced endoscopy systems, which are crucial components for visualizing internal anatomy during minimally invasive procedures.
• Siemens Healthineers: Siemens Healthineers operates in the image-guided therapy market by providing high-resolution intraoperative imaging technologies, such as the ARTIS angiography systems and the Cios series of mobile C-arms.
• Koninklijke Philips N.V.: Philips is a key player with its Azurion image-guided therapy system, which offers enhanced imaging capabilities and streamlined workflows for cardiovascular and neurovascular diseases.

Image Guided Surgery Devices Market Top Companies

• GE Healthcare
• Medtronic Plc.
• Olympus Corporation
• Siemens Healthineers
• Koninklijke Philips N.V.
• Analogic Corporation
• Brainlab AG
• Karl Storz Gmbh & Co. KG
• Stryker Corporation
• Varian Medical Systems Inc.

Market Segmentation

By Product

• Image Guided Surgery Devices
  • Computed Tomography (CT) Scanners
  • Ultrasound Systems
  • Magnetic Resonance Imaging (MRI)
  • Endoscopes
  • X-ray Fluoroscopy Devices
  • Positron Emission Tomography (PET) Devices
  • Single Photon Emission Computed Tomography (SPECT) Devices
• Image Guided Surgery Software

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research & Academic Institutions

By Application

• Cardiac Surgery
• Neurosurgery
• Orthopedic Surgery
• Urology
• Oncology Surgery
• Gastroenterology
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)